{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:31:14Z","timestamp":1792099874997,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270097"],"award-info":[{"award-number":["82270097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070018"],"award-info":[{"award-number":["82070018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901664"],"award-info":[{"award-number":["81901664"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2020JJ5894"],"award-info":[{"award-number":["2020JJ5894"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2024M753695"],"award-info":[{"award-number":["2024M753695"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaut.2024.103341","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T22:29:54Z","timestamp":1732228194000},"page":"103341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["EZH2 promotes B-cell autoimmunity in primary Sjogren's syndrome via METTL3-mediated m6A modification"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-7956","authenticated-orcid":false,"given":"Yiying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2024.103341_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary sj\u00f6gren's syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103341_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41584-023-00932-6","article-title":"Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies","volume":"19","author":"Thorlacius","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103341_bib3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","article-title":"Advances in understanding the pathogenesis of primary Sj\u00f6gren's syndrome","volume":"9","author":"Nocturne","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103341_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-021-00728-6","article-title":"Sj\u00f6gren's syndrome: a systemic autoimmune disease","volume":"22","author":"Negrini","year":"2022","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jaut.2024.103341_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.684999","article-title":"The multiple roles of B cells in the pathogenesis of sj\u00f6gren's syndrome","volume":"12","author":"Du","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103341_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jdsr.2019.09.006","article-title":"B cell dysregulation in primary Sj\u00f6gren's syndrome: a review","volume":"55","author":"Ibrahem","year":"2019","journal-title":"Jpn Dent Sci Rev"},{"key":"10.1016\/j.jaut.2024.103341_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/1744666X.2014.891439","article-title":"B-cell hyperactivity in primary Sj\u00f6gren's syndrome","volume":"10","author":"Kroese","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaut.2024.103341_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/art.42683","article-title":"Multimodal single-cell sequencing of B cells in primary sj\u00f6gren's syndrome","volume":"76","author":"Arvidsson","year":"2024","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103341_bib9","article-title":"EZH2: its regulation and roles in immune disturbance of SLE","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jaut.2024.103341_bib10","article-title":"EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy","volume":"1877","author":"Sun","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.jaut.2024.103341_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2024.103341_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","article-title":"EZH2: a novel target for cancer treatment","volume":"13","author":"Duan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jaut.2024.103341_bib13","article-title":"EZH2 promotes T follicular helper cell differentiation through enhancing STAT3 phosphorylation in patients with primary sj\u00f6gren's syndrome","volume":"13","author":"He","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103341_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108613","article-title":"The role of m6A RNA methylation in cancer","volume":"112","author":"Sun","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jaut.2024.103341_bib15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2023.01.006","article-title":"RNA m6A methylation across the transcriptome","volume":"83","author":"Sendinc","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.jaut.2024.103341_bib16","article-title":"The role of m6A modifications in B-cell development and B-Cell-Related diseases","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2024.103341_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107819","article-title":"Control of early B cell development by the RNA N6-methyladenosine methylation","volume":"31","author":"Zheng","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jaut.2024.103341_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110778","article-title":"YTHDF2 suppresses the plasmablast genetic program and promotes germinal center formation","volume":"39","author":"Grenov","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jaut.2024.103341_bib19","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210360","article-title":"The germinal center reaction depends on RNA methylation and divergent functions of specific methyl readers","volume":"218","author":"Grenov","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2024.103341_bib20","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.4049\/jimmunol.2101071","article-title":"Mettl14-Mediated m6A modification is essential for germinal center B cell response","volume":"208","author":"Huang","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103341_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.949206","article-title":"Alterations of m6A RNA methylation regulators contribute to autophagy and immune infiltration in primary Sj\u00f6gren's syndrome","volume":"13","author":"Cheng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103341_bib22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12886-023-02988-0","article-title":"Increased METTL3 expression and m6A RNA methylation may contribute to the development of dry eye in primary Sj\u00f6gren's syndrome","volume":"23","author":"Ma","year":"2023","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103341_bib23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103341_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2014-000022","article-title":"EULAR Sj\u00f6gren's syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2024.103341_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/dna.2023.0374","article-title":"PANoptosis features, a humanized NSG murine model of Sjogren\u2019s syndrome","volume":"43","author":"Yang","year":"2024","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.jaut.2024.103341_bib26","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/s41423-022-00943-5","article-title":"Aryl hydrocarbon receptor activation drives polymorphonuclear myeloid-derived suppressor cell response and efficiently attenuates experimental Sj\u00f6gren's syndrome","volume":"19","author":"Wei","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jaut.2024.103341_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110155","article-title":"EZH2 inhibition dampens autoantibody production in lupus by restoring B cell immune tolerance","volume":"119","author":"Yang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaut.2024.103341_bib28","first-page":"E565","article-title":"Diagnostic evaluation of serial sections of labial salivary gland biopsies in Sjogren's syndrome","volume":"12","author":"Scardina","year":"2007","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"10.1016\/j.jaut.2024.103341_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/annrheumdis-2021-220066","article-title":"Rheumatoid arthritis, systemic lupus erythematosus and primary Sj\u00f6gren's syndrome shared megakaryocyte expansion in peripheral blood","volume":"81","author":"Wang","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103341_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jaut.2024.103341_bib31","doi-asserted-by":"crossref","first-page":"eadj4857","DOI":"10.1126\/science.adj4857","article-title":"A blueprint for tumor-infiltrating B cells across human cancers","volume":"384","author":"Ma","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jaut.2024.103341_bib32","doi-asserted-by":"crossref","first-page":"D721","DOI":"10.1093\/nar\/gky900","article-title":"CellMarker: a manually curated resource of cell markers in human and mouse","volume":"47","author":"Zhang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2024.103341_bib33","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4049\/jimmunol.1701470","article-title":"EZH2 represses the B cell transcriptional program and regulates antibody-secreting cell metabolism and antibody production","volume":"200","author":"Guo","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103341_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clim.2017.10.008","article-title":"Increased proportion of a CD38highIgD+ B cell subset in peripheral blood is associated with clinical and immunological features in patients with primary Sj\u00f6gren's syndrome","volume":"187","author":"Ishioka-Takei","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2024.103341_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-023-01791-1","article-title":"m6A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma","volume":"22","author":"Fang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jaut.2024.103341_bib36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41584-021-00740-w","article-title":"New hope for B cell-targeting therapy in pSS","volume":"18","author":"Clarke","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103341_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103341_bib38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/annrheumdis-2019-216428","article-title":"Elevated EPSTI1 promote B cell hyperactivation through NF-\u03baB signalling in patients with primary Sj\u00f6gren's syndrome","volume":"79","author":"Sun","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103341_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1102","article-title":"PRMT5 participates in B cell overactivation in patients with primary Sjogren's syndrome (pSS) through RSAD2-mediated NF-\u03baB signaling","volume":"11","author":"Zhu","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaut.2024.103341_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103243","article-title":"Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sj\u00f6gren's syndrome: novel biomarkers for disease activity and subsets","volume":"147","author":"Ritter","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103341_bib41","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/imm.13580","article-title":"mTORC1-GLUT1-mediated glucose metabolism drives hyperactivation of B cells in primary Sjogren's syndrome","volume":"168","author":"Luo","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2024.103341_bib42","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3389\/fimmu.2014.00596","article-title":"Regulation of germinal center, B-cell memory, and plasma cell formation by histone modifiers","volume":"5","author":"Good-Jacobson","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103341_bib43","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/14728222.2019.1696309","article-title":"Therapeutic potential of enhancer of zeste homolog 2 in autoimmune diseases","volume":"23","author":"Yang","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jaut.2024.103341_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ni876","article-title":"Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement","volume":"4","author":"Su","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2024.103341_bib45","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/art.42492","article-title":"Ezh2 knockout in B cells impairs plasmablast differentiation and ameliorates lupus-like disease in MRL\/lpr mice","volume":"75","author":"Zheng","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103341_bib46","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.40931","article-title":"Inhibition of EZH2 ameliorates lupus-like disease in MRL\/lpr mice","volume":"71","author":"Rohraff","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103341_bib47","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/art.41208","article-title":"Methionine commits cells to differentiate into plasmablasts through epigenetic regulation of BTB and CNC homolog 2 by the methyltransferase EZH2","volume":"72","author":"Zhang","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103341_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216706","article-title":"EZH2-mediated development of therapeutic resistance in cancer","volume":"586","author":"Kaur","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jaut.2024.103341_bib49","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41467-017-01029-x","article-title":"EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop","volume":"8","author":"B\u00e9guelin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2024.103341_bib50","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41467-018-04125-8","article-title":"Plasma cell differentiation is controlled by multiple cell division-coupled epigenetic programs","volume":"9","author":"Scharer","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2024.103341_bib51","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-20-2147","article-title":"EZH2-Targeted therapies in cancer: hype or a reality","volume":"80","author":"Eich","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.jaut.2024.103341_bib52","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S1470-2045(20)30441-1","article-title":"Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial","volume":"21","author":"Morschhauser","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jaut.2024.103341_bib53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40265-020-01288-x","article-title":"Tazemetostat: first approval","volume":"80","author":"Hoy","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.jaut.2024.103341_bib54","article-title":"EZH2 inhibition interferes with the activation of type I interferon signaling pathway and ameliorates lupus nephritis in NZB\/NZW F1 mice","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103341_bib55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13075-020-02225-9","article-title":"Ezh2-mediated epigenetic modification is required for allogeneic T cell-induced lupus disease","volume":"22","author":"Zhen","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2024.103341_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102404","article-title":"EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis","volume":"108","author":"Xiao","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103341_bib57","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.20171417","article-title":"Macrophage\/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3","volume":"215","author":"Zhang","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2024.103341_bib58","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1073\/pnas.1813006116","article-title":"Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma","volume":"116","author":"Tsou","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2024.103341_bib59","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13075-020-02376-9","article-title":"Long non-coding RNA HOTAIR induces GLI2 expression through Notch signalling in systemic sclerosis dermal fibroblasts","volume":"22","author":"Wasson","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2024.103341_bib60","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/annrheumdis-2019-216542","article-title":"Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH","volume":"79","author":"Wasson","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103341_bib61","article-title":"RNA N6-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m6A-GLUT1-mTORC1 Axis and is a therapeutic target","volume":"160","author":"Chen","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2024.103341_bib62","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","article-title":"Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis","volume":"79","author":"Wang","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2024.103341_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217047","article-title":"YTHDF1 promotes the osteolytic bone metastasis of breast cancer via inducing EZH2 and CDH11 translation","volume":"597","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jaut.2024.103341_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T11:42:11Z","timestamp":1738496531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124001756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":64,"alternative-id":["S0896841124001756"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103341","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EZH2 promotes B-cell autoimmunity in primary Sjogren's syndrome via METTL3-mediated m6A modification","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103341"}}